Corrigendum to ‘Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-Versus Host Disease Guided Multiple DLIs Could Improve Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Refractory/Relapsed Acute Leukemia’ [Biology of Blood and Marrow Transplantation 23/8 (2017) 1311-1319]
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2019.03.006
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Elsevier BV